TOKYO, Sept 6 (Reuters) – Japan’s Sumitomo Dainippon Pharma Co will pay $3 billion for a 10% stake in Swiss drugmaker Roivant Sciences Ltd and interests in five of its biopharmaceutical businesses, …
More UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push Videos